Skip to content

A Multicenter, Randomized, Controlled, Open Label Trial for Shenfu Injection in the Treatment of Septic Shock

A Multicenter, Randomized, Controlled, Open Label Trial for Shenfu Injection in the Treatment of Septic Shock

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019794
Enrollment
Unknown
Registered
2018-11-29
Start date
2018-11-30
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. diagnosis of septic shock; 2. Aged 18-80 years old; 3. Lactic acid level=4.0mmol/L; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Possible death within 24 hours; 2. need of cardiopulmonary resuscitation; 3. Patients with advanced malignant tumors; 4. Patients with acute coronary artery disease, such as acute myocardial infarction; 5. Patients with rheumatic immune diseases and other long-term maintenance hormone therapy; 6. Septic shock caused by viral infection or serious infectious diseases; 7. Allergic to Shenfu Injection or the excipients listed in the preparations and ingredients of Red Ginseng and Supplementary Tablets; 8. allergic constitution; 9. Pregnancy, pregnancy planning or lactation women; 10. have participated in other clinical trials in the past three months; 11. Clinical researchers believe that there are other situations that are not suitable for the study.

Design outcomes

Primary

MeasureTime frame
28 day mortality;PD-1/PD-L1;

Secondary

MeasureTime frame
lactate;MAP;Incidence of MODS;7 day mortality;HOD;Inflammatory factors;

Countries

China

Contacts

Public ContactLi Jun

Guangdong Provincial Hospital of Chinese Medicine

lijun1401@163.com+86 13728065350

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026